USFDA – Page 3 – Express Pharma

Biocon Biologics gains USFDA approval for Kirsty, Interchangeable Rapid-Acting Insulin Aspart

Lupin gains USFDA approval for Loteprednol Etabonate Ophthalmic Gel

Addressing US FDA challenges in Indian sterile drug manufacturing – Part 3

Addressing US FDA challenges in Indian sterile drug manufacturing – Part 2

What the new drug rules mean for quality control in Pharma: From lab to license

Alembic gains USFDA final approval for Amlodipine & Atorvastatin Tablets USP, 2.5 mg/10 mg, 2.5 mg/20 mg, 2.5 mg/40 mg, 5 mg/10 mg, 5 mg/20 mg, 5 mg/40 mg, 5 mg/80 mg, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg, & 10 mg/80 mg

Indoco Remedies gains USFDA final approval for Allopurinol Tablets USP 200 mg

Lupin gains USFDA approval for Rivaroxaban Tablets USP, 10 mg, 15 mg, and 20 mg

Lupin launches Tolvaptan Tablets in the US

Lupin gains USFDA nod for Raltegravir Tablets USP, 600 mg